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Abstract
 
Tuberculosis is a major cause of death in much of the world. Current estimates are that one-
third of the world’s population is infected with 
 
Mycobacterium tuberculosis
 
. Most infected persons
control the infection but in many cases may not eliminate the organism. Reactivation of this
clinically latent infection is responsible for a large proportion of active tuberculosis cases. A ma-
jor risk factor for reactivation of latent tuberculosis is HIV infection, suggesting a role for the
CD4
 
1
 
 T cell subset in maintaining the latent persistent infection. In this study, we tested the
requirement for CD4
 
1
 
 T cells in preventing reactivation in a murine model of latent tubercu-
losis. Antibody-mediated depletion of CD4
 
1
 
 T cells resulted in rapid reactivation of a persis-
tent infection, with dramatically increased bacterial numbers in the organs, increased pathology
in the lungs, and decreased survival. Although CD4
 
1
 
 T cells are believed to be a major source
of interferon (IFN)-
 
g
 
, expression of the gene for IFN-
 
g
 
 in the lungs of CD4
 
1
 
 T cell–depleted
mice was similar to that in control mice. In addition, inducible nitric oxide synthase produc-
tion and activity was unimpaired after CD4
 
1
 
 T cell depletion, indicating that macrophage acti-
vation was present even during CD4
 
1
 
 T cell deficiency. These data indicate that CD4
 
1
 
 T cells
are necessary to prevent reactivation but may have roles in addition to IFN-
 
g
 
 production and
macrophage activation in controlling a persistent tuberculous infection.
Key words:
 
Mycobacterium tuberculosis 
 
• bacterial infection • macrophage • lung • nitric oxide 
synthase
 
Introduction
 
Mycobacterium tuberculosis
 
, the etiologic agent of tuberculosis,
was responsible for an estimated 8 million cases of tuberculo-
sis and 1.5 million deaths worldwide in 1998 (1). In humans,
the majority of 
 
M
 
.
 
 tuberculosis
 
 infections are initially con-
trolled, and a clinically latent infection is established, charac-
terized by the persistence of low numbers of possibly dormant
 
bacilli. A small but significant percentage (
 
z
 
10%) of latent in-
fections reactivate years to decades later to give rise to reacti-
vation tuberculosis (2). Aging (3) and iatrogenic immunosup-
pression (4) have been associated with reactivation of human
latent infections. In recent years, HIV infection has emerged
as the biggest risk factor for reactivation of latent tuberculosis
 
(5). The severe CD4
 
1
 
 T cell deficiency in AIDS implicates
CD4
 
1
 
 T cells in protection against reactivation tuberculosis.
Cell-mediated immunity, contributed by both CD4
 
1
 
and CD8
 
1
 
 T lymphocytes, plays an essential role in con-
taining acute 
 
M
 
.
 
 tuberculosis
 
 infection in murine models (for
review see reference 6). Studies in mouse models using an-
tibody depletion (7–9), adoptive transfer (10), and trans-
genic mouse strains deficient in either MHC class II (11,
12) or CD4 (12) have established the absolute requirement
for CD4
 
1
 
 T cells in controlling an acute 
 
M
 
.
 
 tuberculosis
 
challenge. The key role of the CD4
 
1
 
 T cell in tuberculosis
is thought to be its ability to produce the cytokine IFN-
 
g
 
,
which is essential in the control of experimental tuberculo-
sis in mice (13, 14) and is the first identified human immu-
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nologic factor essential to resistance against mycobacterial
infection (15). IFN-
 
g
 
 is a critical factor for inducing mac-
rophage synthesis of the enzyme inducible nitric oxide syn-
thase (NOS2)
 
1
 
 (14, 16). Upon activation, macrophages
generate nitric oxide and other reactive nitrogen interme-
diates (RNIs), the best characterized antituberculous effec-
tor molecules in the mouse (for review see reference 17).
Evidence is mounting that RNIs also play a role in antimy-
cobacterial defense in humans (18). It is also likely that
RNI-independent mechanisms induced by IFN-
 
g
 
 partici-
pate in protection against tuberculosis (17, 19).
Despite the large body of knowledge on the immune re-
sponse required to control an experimental acute 
 
M
 
.
 
 tubercu-
losis
 
 infection, little is known about the immunologic mech-
anisms responsible for maintaining a latent infection. Studies
using persistent tuberculosis in mice to model latent tubercu-
losis in humans have demonstrated that RNIs are required to
prevent reactivation of persistent infection (19, 20). IFN-
 
g
 
and TNF-
 
a
 
 also participate in maintenance of persistent 
 
M
 
.
 
tuberculosis
 
 infection in mice (21, 22, and Mohan, V.P., C.A.
Scanga, K. Yu, H.M. Scott, K.E. Tanaka, E. Tsang, J.L.
Flynn, and J. Chan, manuscript submitted for publication).
Although CD4
 
1
 
 T cells clearly are important early in the
course of 
 
M
 
.
 
 tuberculosis
 
 infection, the role of these cells be-
yond the acute phase of infection when a vigorous immune
response has been established is unknown. CD4
 
1
 
 T cell–
deficient mice succumbed to acute tuberculosis, although the
level of IFN-
 
g
 
 was merely delayed compared with control
mice; a compensatory increase in CD8
 
1
 
 T cells producing
IFN-
 
g
 
 occurred by 4 wk after infection (12). This suggested
that subsequent to the induction of an immune response to
the infection, other cells might be capable of producing
IFN-
 
g
 
, reducing the requirement for CD4
 
1
 
 T cells.
In this study, we tested whether CD4
 
1
 
 T cells are re-
quired to prevent reactivation tuberculosis, using a previ-
ously described murine model of persistent tuberculosis
(19). Depletion of CD4
 
1
 
 T cells resulted in marked reacti-
vation of the infection. However, the expression of IFN-
 
g
 
and NOS2 in the lungs of CD4
 
1
 
 T cell–depleted mice was
similar to that in control mice, suggesting that the mecha-
nism by which CD4
 
1
 
 T cells maintain a quiescent infection
is not simply production of IFN-
 
g
 
.
 
Materials and Methods
 
Mice.
 
8–10-wk-old female C57BL/6 mice (The Jackson Lab-
oratory and Charles River Laboratories) were housed in microiso-
lator cages under specific pathogen–free biosafety level 3 conditions
and monitored for various viruses, bacteria, and parasites. All ani-
mal protocols used in this study were approved by the Institutional
Animal Care and Use Committees at Albert Einstein College of
Medicine and the University of Pittsburgh School of Medicine.
 
Mycobacteria and Infection.
 
The virulent Erdman strain (The
Trudeau Institute, Saranac Lake, NY) of 
 
M
 
.
 
 tuberculosis
 
 was passed
through mice, grown once in culture, and frozen in aliquots. For in-
 
fections, an aliquot was thawed, diluted in PBS with 0.05% Tween-
80, and briefly sonicated in a cup horn sonicator, and 100 
 
m
 
l (con-
taining 5 
 
3
 
 10
 
3
 
 viable bacilli) was injected into mice via a lateral tail
vein. The low-dose latency model, described previously (19), was
used in this study. In brief, mice were infected with 
 
M
 
.
 
 tuberculosis
 
.
Within 1 mo, the numbers of bacilli in the lungs and spleen reach
10
 
5
 
–10
 
6
 
 and the infection is stably maintained for 
 
.
 
10 mo.
 
In Vivo Depletion of CD4
 
1
 
 T Cells.
 
6–8 mo after infection,
during the period of stable infection, CD4
 
1
 
 T cells were depleted
in vivo using 0.5 mg of rat anti-CD4 mAb GK1.5 delivered intra-
peritoneally weekly (
 
n
 
 5 
 
20 mice per experiment). The GK1.5
hybridoma (ATCC) was used to produce ascites (Harlan Bioprod-
ucts for Science) and has been used by others for in vivo CD4
 
1
 
 T
cell depletion (23). The ascites were subjected to sodium ammo-
nium sulfate precipitation to obtain CD4-specific IgG. Similarly
infected control mice (
 
n
 
 5 
 
19 mice per experiment) received nor-
mal rat IgG (Jackson ImmunoResearch Laboratories). Mice that
became moribund during the infection were humanely killed.
 
CFU Determination. 
 
Organs were homogenized in PBS/
0.05% Tween-80 and dilutions were plated on 7H10 agar. Plates
were incubated at 37
 
8
 
C in 5% CO
 
2
 
, and colonies were enumer-
ated after 21 d.
 
Histology and Immunohistochemistry.
 
Formalin-fixed, paraffin-
embedded tissue sections were stained with hematoxylin and eosin
for histological analysis and for acid fast bacilli using Kinyoun’s
method (Difco Labs.) according to the manufacturer’s directions.
Immunohistochemical staining for NOS2 was performed as de-
scribed previously (19). In brief, formalin-fixed, paraffin-embedded
tissue sections were deparaffinized, subjected to microwave antigen
retrieval, and stained using rabbit anti-NOS2 antibody (Transduc-
tion Labs.), followed by biotinylated anti–rabbit IgG (Vector
Labs.). Visualization of antibody for NOS2 was accomplished us-
ing an ABC kit (Vector Labs.) and diaminobenzidine (DAB) or
3-amino-9-ethyl-carbazole substrate (Sigma-Aldrich) followed by a
hematoxylin counterstain. Nitrotyrosine was detected in similarly
treated tissue sections using a rabbit polyclonal antinitrotyrosine an-
tibody (Upstate Biotechnology) with DAB substrate and a methyl
green counterstain. Antibody specificity was confirmed by preincu-
bating the primary antibody with 10 mM 3-nitro-
 
l
 
-tyrosine
(Sigma-Aldrich) before incubation with the tissue sections.
 
FACS
 
®
 
 Analysis.
 
To determine the efficacy of GK1.5 anti-
CD4 mAb for CD4
 
1
 
 T cell depletion in vivo, single-cell suspen-
sions were prepared by passing spleens harvested from long term–
infected mice treated with GK1.5 or normal rat IgG through
mesh bags (Bally Ribbon Mills). RBCs were lysed with Tris/
NH
 
4
 
Cl, and the cells were stained with mAbs directed against
CD3, CD4, and CD8 (clones 145-2C11, H129.19, and 53-6.7,
respectively; BD PharMingen) at 0.2 
 
m
 
g/10
 
6
 
 cells. The cells were
fixed with 2% paraformaldehyde and subjected to three-color
FACS
 
®
 
 analysis using CELLQuest™ software on a FACSCali-
bur™ (Becton Dickinson). Cells were gated on lymphocytes by
forward and side scatter parameters.
 
Intracellular Cytokine Staining.
 
All antibodies used in FACS
 
®
 
analysis were obtained from BD PharMingen. Single-cell suspen-
sions of lungs were prepared as above. Cells were stimulated
overnight with anti-CD3 and anti-CD28 mAb (clones 145-2C11
and 37.51, respectively) at 0.1 and 1.0 
 
m
 
g/ml, respectively. Mo-
nensin (3 
 
m
 
M) was added for the final 6 h. Cells were then stained
for the surface markers CD4 and CD8 as above, permeabilized
with saponin, and stained for intracellular IFN-
 
g
 
 (anti–IFN-
 
g
 
–PE
mAb; clone XMG1.2). Cells were fixed with 1% paraformalde-
hyde and analyzed by three-color FACS
 
®
 
. Cells were gated on
lymphocytes by forward and side scatter parameters.
 
1
 
Abbreviations used in this paper:
 
 NOS, nitric oxide synthase; RNIs, reac-
tive nitrogen intermediates; RPA, ribonuclease protection assay. 
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Ribonuclease Protection Assay.
 
Total RNA was isolated from
flash-frozen lungs using Trizol (GIBCO BRL) according to man-
ufacturer’s instructions, with an additional phenol-chloroform
extraction before RNA precipitation. Gene expression was as-
sessed using the RiboQuant™ ribonuclease protection assay
(RPA) system (BD PharMingen) using customized template sets
that included probes for NOS2, IFN-
 
g
 
, IL-12p40, TNF-
 
a
 
, IL-
1
 
a
 
, and IL-1b and the GAPDH and L32 housekeeping genes in
one set and IL-4, IL-12p40, IL-10, IL-1a, IL-1b, IFN-g,
GAPDH, and L32 in another. Expression of cell surface marker
genes was analyzed with the CD-1 RPA probe (BD PharMin-
gen). Band intensities on the autoradiographs were quantitated by
densitometry (Personal Densitometer SI; Molecular Dynamics),
and the ratio of band intensity between the gene of interest and a
housekeeping gene, either GAPDH or L32, was calculated.
Statistical Analysis. Where appropriate, values were tested for sta-
tistical significance by unpaired Student’s t test using InStat (v.2.03;
GraphPad Software). CFU values were subjected to log transforma-
tion before analysis. P values ,0.05 were considered to be significant.
Results
Course of Chronic Persistent Infection after CD41 T Cell De-
pletion. A murine model of latent human tuberculosis (19)
was used to assess the contribution of CD41 T cells to pre-
venting reactivation. C57BL/6 mice were infected intrave-
nously with 5 3 103 CFU M. tuberculosis Erdman strain, and
the infection was allowed to progress for 6–8 mo. As detailed
previously (19), the bacillary burden in the lungs, spleen, and
liver increased for 3–4 wk after infection. As a cellular im-
mune response to the infection is established, the numbers of
bacilli stabilize in the organs and remain essentially unchanged
for at least 10 mo. During this period, the mice remain clini-
cally healthy. This prolonged period of stable bacillary num-
bers in an apparently healthy animal may be best character-
ized as a persistent or chronic infection but can serve as a
useful experimental model of human latent tuberculosis.
6 mo after infection, during the period of stable bacterial
load, CD41 T cells were depleted in vivo by weekly admin-
istration of rat anti–murine CD4 mAb GK1.5. Splenocytes
were analyzed by FACS® to evaluate the efficacy of the de-
pletion regimen 11 d after initiation of the antibody treat-
ment. GK1.5-treated mice exhibited a 93% reduction in the
number of splenic CD41 T cells as compared with similarly
infected control mice receiving normal rat IgG at this time
point (1.7% CD41 T cells [mean, two mice] versus 22.7%;
Figure 1. Bacterial burdens in organs after depletion of
CD41 T cells in mice latently infected with M. tuberculosis.
C57BL/6 mice were infected with 5 3 103 CFU of M. tu-
berculosis Erdman strain and 6 (A) or 8 mo (B) later were
injected twice weekly with GK1.5 monoclonal anti-CD4
to deplete CD41 T cells (open symbols) or with control
IgG (closed symbols). Mice were killed at intervals after
the antibody regimen was begun, and the lungs (top pan-
els), spleens (center panels), and livers (bottom panels)
were homogenized, plated onto 7H10, and enumerated af-
ter 21 d. Each point comprises data from three to five
mice; bars represent SE. *P , 0.05; **P , 0.005.350 Depletion of CD41 T Cells Reactivates Persistent Tuberculosis
n 5 1). The number of CD81 T cells was unchanged in
GK1.5-treated mice compared with control mice (13.4 ver-
sus 14.0%). The bacillary burden increased steadily in lung,
liver, and spleen beginning as early as 2 wk after depletion of
CD41 T cells, while the numbers of bacilli in the organs of
animals receiving normal rat IgG remained unchanged (Fig.
1 A). By 9 wk of antibody treatment, the GK1.5-treated
mice had z60-fold more mycobacteria in the lungs and
spleen and 400-fold more in the liver compared with IgG-
treated control mice (Fig. 1 A). Although specific mice were
not set aside in this experiment to follow mortality, 2 of 20
CD41 T cell–depleted mice succumbed to tuberculosis (at
50 and 56 d of GK1.5 treatment) throughout the course of
this experiment, while all control mice appeared healthy. In
a second trial in which mice were infected for 8 mo before
anti-CD4 treatment, the kinetics of tissue bacterial burden
were virtually identical in GK1.5-treated mice (Fig. 1 B).
CD41 T cell–depleted mice exhibited a mean survival time
of 76 6 25 d with 100% mortality by 109 d of antibody
treatment (range 46–109 d; n 5 9 mice followed for mortal-
ity of 25 total). 4 of 25 control IgG–treated mice died dur-
ing the antibody treatment period at 27, 35, 54, and 97 d of
treatment. Although the bacillary burdens were not deter-
mined in the animals that died, analysis of other control mice
indicated that bacterial numbers and pathology remained sta-
ble throughout the treatment period (Fig. 1 B). It is likely
that the four deaths in the control IgG mice were not due to
progression of tuberculosis but instead may have been caused
by inadvertent penetration of visceral organs during antibody
administration. In sum, depletion of CD41 T cells was detri-
mental to control of chronic persistent tuberculosis.
Pathology in Persistently Infected Mice after CD41 T Cell
Depletion. Tissue sections from the CD41 T cell–depleted
and control mice were examined for histopathology. Not
surprisingly, substantial pathology was present in lungs of
both GK1.5- and control antibody–treated mice, as both
groups had been persistently infected with M. tuberculosis
for .6 mo. In control mice receiving normal rat IgG, the
granulomatous response in the lungs consisted of well de-
lineated lymphoid aggregates containing a minor mono-
cytic component, situated among a predominately lympho-
histiocytic infiltrate with poorly defined margins. There
was an abundance of foamy macrophages, some of which
were intraalveolar (Fig. 2, A and C). Alveolitis and intersti-
tial pneumonitis were also observed. In the CD41 T cell–
depleted mice, a gradual disappearance of the lymphoid ag-
gregates was apparent such that they were barely detectable
microscopically by 63 d of GK1.5 treatment (Fig. 2, B and
D). Most striking was the prominence of necrosis in the
pulmonic granulomata of the CD41 T cell–depleted mice,
involving multiple areas with marked destruction of the
lung architecture (Fig. 2 D), particularly at later time points
when tissue bacillary burden was high. Eosinophilic plasma
cells (Mott cells) were noted in granulomatous areas in the
lungs of both the CD41 T cell–depleted and control mice.
These histopathologic findings are consistent with the in-
creased CFU in organs of GK1.5-treated mice, in that high
bacterial numbers are frequently associated with necrosis of
lung tissue (24). Histologic stains for Pneumocystis carinii
were negative (data not shown) and excluded this opportu-
nistic pathogen as contributing to the histopathology ob-
served in the CD41 T cell–depleted mice.
Figure 2. Histopathology in
lungs of mice persistently in-
fected with M. tuberculosis and
then depleted of CD41 T cells.
Mice were infected with M. tu-
berculosis for 6 mo and then
treated with GK1.5 monoclonal
anti-CD4 or control IgG. Lungs
were harvested 2 (top panels) or
9 wk (bottom panels) into the
antibody regimens. Foamy alve-
olar macrophages (arrows) are
apparent in both groups. Origi-
nal magnification, 1003; insets,
4003. Micrographs from sec-
tions of representative mice are
shown; sections from three to
five mice per group per time
point were examined, and simi-
lar results were obtained in a re-
peat experiment.351 Scanga et al.
NOS2 Expression and Activity in CD41 T Cell–depleted
Mice. The expression of NOS2 protein in lungs, spleen,
and liver of CD41 T cell–depleted and control mice was
assessed immunohistochemically. High levels of NOS2
protein localized to foamy macrophages within granuloma-
tous areas were observed at 6 mo after infection, before an-
tibody treatment, as previously described (19; data not
shown). There was no discernible difference in tissue
NOS2 expression between GK1.5- and normal IgG-
treated mice after 2 wk (Fig. 3, A and E), 6 wk (Fig. 3, B
and F), or 9 wk (data not shown) of antibody treatment.
The loss of CD41 T cells did not appear to affect the num-
ber of NOS2-positive cells (Table I), the distribution of
those cells, nor the intensity of NOS2 staining in the lung.
This observation was supported by RPA analyses of total
lung RNA from GK1.5 and control mice (Fig. 4). Expres-
sion of the NOS2 gene was similar between CD41 T cell–
depleted and control mice at all time points. More direct
evidence of continued production of RNIs in the CD41 T
cell–depleted mice was provided by immunostaining tissue
sections from these mice using antinitrotyrosine antibody
to detect nitrated proteins. Nitrotyrosine is generated via
nitration of tyrosine by peroxynitrite, a product of NO and
superoxide anion, and thus reflects NOS2 activity. Nitroty-
rosine staining was similar in the lung tissue and granulo-
mas of GK1.5- and normal IgG-treated mice (Fig. 3, C and
H). When the antinitrotyrosine antibody was preincubated
with nitrotyrosine before being used in this assay, all stain-
ing was abolished (Fig. 3, D and G), confirming the stain-
ing specificity. These results indicate that CD41 T cell de-
pletion–induced reactivation was not due to a deficiency in
RNI-dependent antimicrobial mechanisms.
Table I. Number of Cells Expressing NOS2 on Lung Sections of Persistently Infected Mice after Initiation of CD41 T Cell Depletion Regimen
2 wk 6 wk 9 wk
Day 0 GK1.5 IgG GK1.5 IgG GK1.5 IgG
70 6 18 78 6 17 101 6 8 102 6 11 114 6 33 153 6 25 181 6 18
P 5 0.30 P 5 0.75 P 5 0.40
Beginning 6 mo after infection with M. tuberculosis, mice were treated with GK1.5 anti-CD4 antibody or control IgG.  At the indicated time intervals
after initiation of antibody treatment, lungs were recovered and immunohistochemically stained for NOS2 expression.  The number of cells stained
positively for NOS2 per 10 1003 fields 6 SE is shown.  Three to five mice per time point per group were examined.
Figure 3. NOS2 protein expression and protein nitration in lungs of mice persistently infected with M. tuberculosis for 6 mo and then depleted of
CD41 T cells. 6 mo after infection, mice were treated with GK1.5 monoclonal anti-CD4 to deplete CD41 T cells (E–H) or control IgG (A–D). Lung
sections were stained for NOS2 protein (A, B, E, and F) 2 wk (A and E) and 6 wk (B and F) into the antibody treatment regimen. Similarly processed
lung sections obtained 6 wk into the antibody regimen were also stained for nitrotyrosine (C and G). Specificity of the nitrotyrosine antibody was con-
firmed by preincubating the nitrotyrosine antibody with nitrotyrosine before staining the sections (D and H). B–D are serial sections, as are F–H. Repre-
sentative sections from four mice per group per time point are shown. Original magnification, 4003.352 Depletion of CD41 T Cells Reactivates Persistent Tuberculosis
IFN-g Production after CD41 T Cell Depletion. IFN-g is
a critical factor required for activating macrophages to pro-
duce NOS2 (14, 16). Therefore, the finding of unimpaired
NOS2 production in CD41 T cell–depleted mice sug-
gested that an alternate source of IFN-g, independent of
CD41 T cells, existed in GK1.5-treated mice. To address
the possible source of IFN-g in the lungs of the mice, cell
populations and cytokine production in the lungs were as-
sessed by FACS® analysis. Staining for CD41 T cells con-
firmed that GK1.5 treatment was efficacious in the lungs,
with .94% depletion of CD41 T cells in lungs of GK1.5-
treated mice compared with normal rat IgG–treated mice
after 4 and 9 wk of antibody treatment (Fig. 5). However,
the mean number of cells recovered from lung tissue did
not differ significantly between GK1.5- and normal rat
IgG–treated mice (Table II). There was an increase in the
percentage of CD81 T cells in CD41 T cell–depleted mice
compared with control IgG–treated mice at both 4 wk
(mean GK1.5, 20.5%; mean control IgG, 10.8%; P 5 0.03)
and 9 wk (mean GK1.5, 34.1%; mean control IgG, 26.9%;
P 5 0.076). Because the numbers of cells recovered from
the lungs of mice from both groups were similar (Table II),
this increased percentage corresponds to an actual increase
in total number of CD81 T cells.
We used intracellular cytokine staining of lung cells to
assess production of IFN-g in the lungs of the CD41 T
cell–depleted, persistently infected mice. Despite effective
depletion of the pulmonic CD41 T cell compartment,
there was not a significant decrease in the percentage of to-
tal lymphocytes producing IFN-g after 4 or 9 wk of deple-
tion compared with IgG-treated control mice. Data from
representative mice are shown in Fig. 5. Lymphocytes from
uninfected mice produce very little IFN-g after ex vivo
stimulation (25). As noted above, there was an increase in
numbers of CD81 T cells in GK1.5-treated mice, and these
CD81 T cells were capable of producing IFN-g (Fig. 5).
RPA analysis of total lung RNA confirmed that the levels
of IFN-g expression in the lungs of GK1.5- and control
IgG–treated mice were indeed comparable (Fig. 4). The ef-
ficacy of GK1.5 treatment, the increase in CD81 T cells
Figure 4. Gene expression in lungs
after depletion of CD41 T cells in
mice persistently infected with M. tu-
berculosis. Persistently infected mice
were injected with GK1.5 to deplete
CD41 T cells (open symbols) or with
control IgG (closed symbols). Mice
were killed at intervals after the anti-
body regimen was begun, total RNA
was isolated from lungs, and mRNA
expression was measured using RPA
with a template specific for NOS2 (A), IFN-g (B), and TNF-a (C) as well as IL-12p40, IL-1a,
IL-1b (not shown), and the housekeeping genes GAPDH and L32. Autoradiographs were
quantitated by densitometry, and the ratio between the gene of interest and a housekeeping
gene was calculated. Each point represents the mean of results obtained from three to five mice,
and bars are SE. *P , 0.05. Similar results were obtained in a repeat experiment. Representative
autoradiograph is shown (D).353 Scanga et al.
upon CD41 T cell depletion, and the comparable IFN-g
expression in the lungs of GK1.5 and control mice was
confirmed in a second CD41 T cell depletion experiment
(data not shown). Taken together, these data indicate that
in the lungs of persistently infected mice depleted of CD41
T cells, there was an increase in CD81 T cells capable of
IFN-g production.
Gene Expression in the Lungs after CD41 T Cell Depletion
in Chronic Persistent Tuberculosis. RPA analysis of total
lung RNA revealed that in the CD41 T cell–depleted
mice, TNF-a expression remained relatively steady, except
at the last time point when a significant increase was ob-
served (Fig. 4). This may reflect the more severe pathology
in the lungs of these mice relative to the mice receiving
normal rat IgG (Fig. 2). Substantial expression of IL-1a and
IL–1b was detected over the course of the antibody treat-
ment regimen, but there was little difference between the
mice receiving GK1.5 and those receiving control antibody
(Fig. 4). A low level of IL-12p40 expression was noted in
both groups and did not vary throughout the antibody
treatment period (data not shown). Expression of IL-4 (Fig.
4) and IL-10 (data not shown) was low or undetectable at
all time points in both groups of mice.
2 wk after initiation of anti-CD4 antibody treatment,
there was a decrease in CD4 gene expression in the lungs
relative to that in mice receiving control antibody, as as-
sessed by RPA (Fig. 6). This difference was significant (P 5
0.002) by 6 wk of antibody treatment and was maintained
throughout the remainder of the experiment (Fig. 6).
These data confirmed the results obtained by FACS® analy-
sis that GK1.5 was efficacious in depleting CD41 T cells in
the lungs over a long treatment period. The expression of
CD3 was not significantly different among the GK1.5- and
rat IgG–treated mice at the various time points studied
(Fig. 6). There was a significant decrease in the expression
of CD19 (a pan-B cell marker) in CD41 T cell–depleted
mice by 6 wk of GK1.5 treatment compared with IgG-
treated mice (P 5 0.001; Fig. 6), suggesting that fewer B
cells were present in those mice.
Discussion
The association between the deficiency of CD41 T cells
observed with AIDS and the incidence of reactivation of
latent tuberculosis suggests that CD41 T cells play an im-
portant role in preventing reactivation tuberculosis. In hu-
man studies, M. tuberculosis–specific CD41 T cells secrete
IFN-g (26), and a recent publication suggests that in vitro
IFN-g can induce human macrophages to kill M. tuberculo-
sis coincident with the expression of NOS2 (27). CD41 T
cells are thought to be the primary source of IFN-g and are
required to control acute M. tuberculosis infection in mice
(7, 8, 10, 12). The importance of IFN-g in controlling my-
cobacterial infections has been demonstrated in humans
Figure 5. Intracellular IFN-g
staining of lung cells 4 wk after be-
ginning CD41 T cell depletion of
persistently infected mice. Lung cells
were disaggregated, stimulated for
16 h with anti-CD3 and anti-CD28
in the presence of monensin for the
final 6 h, fixed in paraformaldehyde,
stained for CD4 and CD8, perme-
abilized, and stained for IFN-g.
Cells were gated on lymphocytes by
forward and side scatter and analyzed
by three-color FACS®. Lungs from
two mice were analyzed from each
group, and dot plots from a repre-
sentative mouse are shown. The
numbers are the percentages of gated
cells in that quadrant.
Table II. CD41 T Cell Depletion Does Not Affect Total Cell 
Numbers in Lungs of Persistently Infected Mice
Treatment
4 wk Ab
treatment
9 wk Ab 
treatment
3106 
Control rat IgG 7.8 5.2
5.0 6.8
GK1.5 3.3 5.6
6.5 6.9
Total cell numbers in lungs of mice infected 6 mo previously with M.
tuberculosis were determined by trypan blue exclusion after preparation
of a single-cell suspension from the lungs. Mice were either treated with
control rat IgG or anti-CD4 antibody (GK1.5).  Values for two mice per
group per time point are shown.  Statistical analysis indicated that values
were not significantly different (P . 0.5) between the two groups at
each time point.  The mean number of cells obtained from uninfected,
untreated mice was 1.2 3 106 cells.354 Depletion of CD41 T Cells Reactivates Persistent Tuberculosis
(for review see reference 15) and mice (13, 14). NOS2 ex-
pression is severely compromised at both the gene (14) and
protein (our unpublished observations) levels in M. tubercu-
losis–infected mice with a disruption in the IFN-g gene,
and these animals succumb quickly to infection (14). In ad-
dition, emerging evidence suggests that both IFN-g (22)
and NOS2 (19, 20) play a role in preventing reactivation of
persistent tuberculosis in murine models of latency.
The requirement for CD41 T cells in preventing reacti-
vation was tested in a murine model of persistent tubercu-
losis in which CD41 T cells were depleted by antibody
treatment beginning 6–8 mo after infection. Depletion of
CD41 T cells resulted in fatal exacerbation of the quiescent
infection with markedly increased bacterial numbers, indi-
cating that CD41 T cells are required to prevent reactiva-
tion. Two surprising findings emerged from this study.
First, depletion of CD41 T cells, arguably the major source
of IFN-g in tuberculous infection, did not result in an ap-
preciable decrease in overall IFN-g production in the
lungs. Second, control of mycobacterial growth was lost in
the CD41 T cell–depleted mice, despite unimpaired NOS2
expression and activity.
CD81 T cells are capable of producing significant
amounts of IFN-g in response to M. tuberculosis in both
murine (11, 12, 25) and human (28, 29) systems. Indeed, in
this study, depletion of CD41 T cells in mice persistently
infected with M. tuberculosis resulted in an increase in the
number of CD81 T cells, a subset of which was producing
IFN-g. Therefore, as in acute tuberculosis models using
CD41 T cell–deficient mice (12), a compensatory increase
in CD81 T cells producing IFN-g in the lungs of GK1.5-
treated mice could at least partially account for the undi-
minished IFN-g expression seen in mice depleted of CD41
T cells. Other cell types cannot be excluded from contrib-
uting to IFN-g production. CD4282 T cells from Leishma-
nia major–infected mice have been shown to produce IFN-g
in vitro (30), although this was not observed in acute tu-
berculosis models in CD41 T cell–deficient mice (12). NK
cells have been implicated as important sources of IFN-g in
the early immunologic response against several infectious
agents, including L. major (31) and Toxoplasma gondii (32).
Finally, macrophages have been reported to produce IFN-g
in response to mycobacteria (33, 34). As cell markers
other than CD8 and CD4 were not analyzed by FACS®,
contribution to the total IFN-g production by these other
cell types cannot be excluded. Whatever the source of the
IFN-g, it is clear that its presence did not prevent reactiva-
tion of the infection and thus did not adequately compen-
sate for the lack of CD41 T cells. Perhaps this cytokine
must be delivered directly to the infected macrophage to be
effective, and cell types other than CD41 T cells may not
do so as efficiently within the granuloma. Studies are un-
derway to determine the precise location of and the cell
type responsible for IFN-g production in the absence of
CD41 T cells in this model.
Studies using murine models of latent tuberculosis have
established the importance of NOS2 in preventing reacti-
vation (19, 20). In this study, however, CD41 T cell deple-
tion resulted in a dramatic increase in the numbers of bacilli
despite levels of NOS2 comparable to that of mice receiv-
ing control IgG. Nitrated tyrosine residues were detected
in lung tissue of both CD41 T cell–depleted and control
mice, and their distribution was colocalized to areas of
NOS2 expression. These data provide evidence that NOS2
gene and protein expression and activity were unaffected
by the depletion of CD41 T cells. NOS2 expression is de-
Figure 6. Changes in lung cell composition after GK1.5 anti-CD4
treatment of mice persistently infected with M. tuberculosis. Mice infected
with M. tuberculosis for 6 mo were injected with GK1.5 (open symbols) or
control IgG (closed symbols), and lung gene expression was measured by
RPA as described in Fig. 4 using a template specific for cell markers in-
cluding CD4 (top), CD3 (center), and CD19 (bottom). Each point repre-
sents the mean of results obtained from three to five mice, and the bars
are SE. *P , 0.05. Similar results were obtained in a repeat experiment.355 Scanga et al.
pendent on IFN-g (14, 16), and thus the unimpaired
NOS2 expression provides further, indirect evidence of
undiminished IFN-g expression in the lungs of CD41 T
cell–depleted mice. These surprising findings suggest that
CD41 T cells prevent reactivation by a mechanism that is
not solely mediated by IFN-g or NOS2-generated RNIs.
Although unlikely, it is possible that there was an unde-
tected decrease in IFN-g and/or NOS2 production immedi-
ately following CD41 T cell depletion, as the earliest post-
depletion time point examined was 2 wk. In acute M.
tuberculosis infection of CD42/2 or MHC class II2/2 mice,
production of wild-type levels of IFN-g and NOS2 was
delayed for only 2 wk (12) and was apparently sufficient to
render these mice very susceptible to tuberculosis. How-
ever, in a chronic infection, macrophages are already
primed to produce NOS2, and a short-lived IFN-g defi-
ciency would be less likely to have an effect than in the im-
munologically naive mice used for the acute tuberculosis
studies. This study raises the question of how the reactivat-
ing bacilli not only survive but actively replicate in the
presence of NOS2 and the resultant RNIs. Although
NOS2-generated RNIs are a necessary antimycobacterial
effector mechanism, it is not sufficient to eliminate M. tu-
berculosis infection in vivo (19, 20, 35).
In light of reactivation in the presence of control levels
of IFN-g and NOS2 in the CD41 T cell–depleted mice,
additional CD41 T cell functions capable of maintaining
latency must be considered. First, the requirement of
CD41 T cells for a vigorous granulomatous reaction in
mycobaterial infection has been reported (12, 36, 37). In
tuberculosis patients coinfected with HIV, the structural
integrity of the tuberculous granuloma appears to correlate
with the number of total peripheral CD41 T cells (38, 39).
Although the pathology and general loss of granuloma
structure observed in the lungs of GK1.5-treated mice dur-
ing reactivation may be directly related to bacterial num-
bers, we cannot exclude a role for CD41 T cells in mainte-
nance of an organized granuloma during latent infection.
Second, a key element in controlling M. tuberculosis infec-
tion is macrophage activation. CD41 T cells may have
IFN-g– and NOS2-independent pathways to activate my-
cobactericidal or mycobacteriostatic effector functions in
macrophages. Macrophages can be activated through direct
contact via interaction between CD40 on macrophages
and CD40L on activated lymphocytes (40), and this can
result in NOS2 induction (41). Although this mechanism
is apparently necessary for successful immunity to L. major
(42–44), CD40L2/2 mice were not more susceptible to M.
tuberculosis infection (45). As negative data in genetically
deficient mice can be difficult to interpret, the role of
CD40 in tuberculosis remains unclear. Third, it is possible
that depletion of CD41 T cells results in increased produc-
tion of cytokines capable of deactivating macrophages.
Two such cytokines are IL-10 (46) and TGF-b (47). In-
deed, in HIV-infected individuals, production of IL-10
and TGF-b by PBMCs is augmented (for review see refer-
ence 48). IL-10 mRNA was expressed at very low levels
that were similar in lungs of CD41 T cell–depleted and
control mice, so this cytokine is not likely to contribute to
the reactivation observed in this model. TGF-b produced
by M. tuberculosis–infected macrophages has been reported
to downregulate macrophage function (49). TGF-b was
not examined in this study, and so the possibility remains
that this cytokine may increase in the absence of CD41 T
cells, leading to macrophage deactivation and increased
bacterial growth. Fourth, CD41 T cells are thought to be
important in maintaining an adequate CD81 T cell re-
sponse (50–52). We and others have demonstrated previ-
ously that CD81 T cells participate in control of tubercu-
losis in mice (9, 11, 25, 53, 54), and the presence of
mycobacterial-specific CD81 T cells in tuberculosis pa-
tients has been recently reported (28, 29, 55). Mycobacte-
ria-specific CD81 T cells can produce IFN-g or act as cy-
totoxic cells for infected macrophages (25, 28, 29, 56, 57).
Recent data indicate that CD81 CTLs that produce granu-
lysin can kill intracellular M. tuberculosis (58). Although
CD81 T cell numbers were increased after CD41 T cell
depletion, and these cells were clearly primed to produce
IFN-g, the actual function of these cells in the lungs in the
absence of CD41 T cells is unclear. Perhaps CD41 T cells
are necessary for complete function or maintenance of
CD81 cytolytic activity, without which control of chronic
persistent tuberculosis is compromised.
Results obtained from RPA analysis of cell surface
marker expression suggested that there was a substantial re-
duction in B cells in the lungs of CD41 T cell–depleted
mice. T cells play an important role in modulating B cell
differentiation, function, and life span. CD41 T cells may
also regulate production of specific B cell chemoattractants.
Plasmacytoid cells were observed in lung sections, but
CD19 is downregulated on fully differentiated B cells in
humans (59, 60), and so this does not contradict the RPA
data. The role of antibodies in immunity to M. tuberculosis is
controversial (61), and B cells may contribute to the im-
mune response to intracellular infections in an antibody-
independent manner, as suggested recently in a Francisella
tularensis murine model (62). Studies using B cell–deficient
mice are contradictory, suggesting that B cells contribute
modestly (63) or not at all (64) to control of M. tuberculosis
infection. A careful analysis of the contribution of B cells in
latent tuberculosis may further define protective mecha-
nisms against reactivation of latent infections.
In this murine model of latent tuberculosis, inhibition of
NOS2 (19), neutralization of TNF-a (Mohan, V.P., C.A.
Scanga, K. Yu, H.M. Scott, K.E. Tanaka, E. Tsang, J.L.
Flynn, and J. Chan, manuscript submitted for publication),
or depletion of CD41 T cells (this study) resulted in reacti-
vation of infection and fatal tuberculosis. However, there
were significant differences in the course of reactivation
and pathology as well as expression of cytokines, depending
on the immunologic manipulation implemented. Inhibi-
tion of NOS2 resulted in slowly progressive reactivation
primarily in the lungs (19), whereas CD41 T cell depletion
resulted in a rapid and dramatic increase in bacterial num-
bers in liver and spleen, as well as lung, shortly after initia-
tion of antibody treatment. TNF-a neutralization caused356 Depletion of CD41 T Cells Reactivates Persistent Tuberculosis
an initial increase in bacterial numbers that stabilized after 3
wk, despite decreased NOS2 expression (Mohan, V.P.,
C.A. Scanga, K. Yu, H.M. Scott, K.E. Tanaka, E. Tsang,
J.L. Flynn, and J. Chan, manuscript submitted for publica-
tion). Severe pathology was observed in TNF-a–neutral-
ized mice that was very different than that observed in
CD41 T cell–depleted mice, with marked disorganization
of granulomata and increased leukocytic infiltration (Mo-
han, V.P., C.A. Scanga, K. Yu, H.M. Scott, K.E. Tanaka,
E. Tsang, J.L. Flynn, and J. Chan, manuscript submitted for
publication). Although interpretations based on interexper-
imental comparisons must be made with prudence, the re-
sults of our previous studies and results presented in this
study suggest that individual immunologic components
play a variety of roles in preventing reactivation, highlight-
ing the complex nature of the protective response in
chronic tuberculosis.
In summary, this study demonstrates the requirement for
CD41 T cells in maintaining a persistent M. tuberculosis in-
fection. However, depletion of CD41 T cells did not result
in decreased tissue expression of IFN-g or NOS2, the two
most characterized CD41 T cell–related antimycobacterial
factors. Thus, the role of the CD41 T cell in persistent tu-
berculosis is more complex than merely as a source of IFN-g
for macrophage activation. Further investigation of the
mechanism by which the CD41 T cell functions during la-
tency may guide the development of therapies and vaccines
designed to prevent reactivation of tuberculosis.
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